Your AI Passed Vendor Tests. Will It Pass Clinical Reality?
Healthcare can't afford to deploy AI on vendor claims and limited testing. We implement comprehensive evaluation frameworks that measure clinical validity, audit for bias, test failure modes, and monitor real-world performance against the standards required in clinical environments.
Most organizations deploy AI based on vendor accuracy claims or internal testing on clean datasets.
This approach might work for consumer applications where failures are inconvenient. In healthcare, inadequate evaluation creates patient safety risks, regulatory exposure, malpractice liability, and trust erosion that can derail entire AI programs.
The stakes are different in healthcare.
The FDA is increasing oversight of clinical AI. Poorly validated systems face regulatory action and potential market withdrawal. One publicized failure can destroy provider and patient confidence across your entire organization, undermining years of investment.
Healthcare AI requires evaluation standards that match the stakes.
Clinical validity testing against physician performance on standardized cases
Bias and fairness audits across demographic groups to prevent healthcare disparities
Adversarial testing to find failure modes and edge cases
Regulatory compliance documentation meeting FDA guidance
Continuous real-world monitoring with outcome correlation and drift detection
Five Risks You Can't Afford
02.
Clinical Validity Assessment
Comparison against clinician performance with rigorous metrics.
Beyond simple accuracy:
Performance on critical conditions where false negatives have serious consequences
Alignment with evidence-based clinical guidelines
Appropriate confidence levels that support rather than override clinical judgment
Sensitivity, specificity, and ROC curve analysis
The question we answer:
Does this AI perform as well as or better than human clinicians on the same cases?
03.
Bias and Fairness Audits
We evaluate across:
Race and ethnicity
Age groups
Sex and gender
Geographic regions
Socioeconomic indicators
The goal:
Ensuring AI performs equitably across all patient populations and doesn't perpetuate existing healthcare disparities.
Why this is non-negotiable:
Healthcare disparities are already a crisis. AI that amplifies them creates both ethical failures and legal liability.
04.
Real-World Monitoring
Continuous tracking after deployment with outcome correlation.
What we monitor:
Clinician agreement rates with AI recommendations
Patient outcomes compared to AI predictions
Performance drift as patient populations and clinical practices change
Edge cases and failure modes emerging in production
Feedback loops where human corrections improve the system
The reality:
AI performance in production often differs from performance in testing. Continuous monitoring catches degradation before it affects patient care.
How We Implement Evaluation
01
Framework Design (Weeks 1-2)
We establish custom evaluation criteria based on your specific use cases and risk tolerance.
What happens:
Test dataset creation with diverse patient populations
Clinician ground truth labeling protocols
Bias assessment methodology specific to your patient demographics
Regulatory compliance requirements based on your use cases and jurisdiction
What you get:
Clear evaluation criteria aligned with clinical standards and regulatory expectations.
Comprehensive Testing (Weeks 3-8)
Pre-deployment validation against established criteria.
Core testing:
Clinical accuracy assessment comparing AI to physician benchmarks
Demographic bias analysis across patient populations
Edge case testing for rare and atypical scenarios
Regulatory compliance documentation preparing for potential FDA or state oversight
Delivered continuously:
Testing results and refinements every 1-2 weeks, not a final report at the end.
02
03
Continuous Monitoring (Weeks 9-12 and ongoing)
Production deployment with real-time performance tracking.
What runs continuously:
Dashboards showing real-world AI performance
Automated drift detection alerting when performance degrades
Human-AI disagreement tracking identifying where clinicians override recommendations and why
Adverse event monitoring flagging potential safety issues
Regular re-evaluation protocols ensuring sustained performance
What you get:
Visibility into AI performance with automated alerts before issues affect patient care.
We don't create custom evaluation standards. We implement the frameworks that regulators and clinical leadership recognize and trust.
When Evaluation Becomes Critical
If you're deploying AI without systematic evaluation, you're accepting risks that are both preventable and potentially catastrophic.
Do you work with health systems that are still early in their AI journey?
How is Scalefresh different from the large consulting firms that also offer AI services?
Do you replace our internal IT or data teams?
What does a typical engagement look like?
How do you handle AI safety and regulatory compliance in healthcare?